Why we are not running a small sample N<30 to show the effectiveness of this treatment? It looks to me it takes so long just to initiate this kind of trial. If the issue is $ may be we can partner with BP even it cuts into our revenue, But better than nothing and just watch the years passed by. My comment is applicable to all trials.